
Biomarin Pharmaceutical (NASDAQ:BMRN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement.
Analysts estimate that Biomarin Pharmaceutical will report an earnings per share (EPS) of $0.17.